Integrated Proteins Board of Directors
Get the latest insights into the leadership at Integrated Proteins. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Vinod Prabhulal Mehta | Chairperson |
| Mr. Karanj D Doshi | Managing Director |
| Mrs. Neepa Praful Kothari | Non Executive Woman Director |
| Mr. Bhalchandra Hiralal Vyas | Ind. Non-Executive Director |
| Mr. Priyansh Tejas Parekh | Ind. Non-Executive Director |
| Ms. Jyoti Jashvantray Kataria | Ind. Non-Executive Director |
Integrated Proteins Share price
INTEGFD
29.41
1.54 (-4.98%)Last updated on 20 Feb, 2026 | 15:18 IST
BUYSELL
Today's High
29.41
Today's Low
29.41
52 Week Low
20.71
52 Week High
63.64
Free Demat with Zero AMC*
Integrated Proteins FAQs
The board at Integrated Proteins consists of experienced professionals, including Mr. Vinod Prabhulal Mehta , Mr. Karanj D Doshi , and others, overseeing the company’s strategic and corporate governance.
Directors at Integrated Proteins are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Vinod Prabhulal Mehta is the current chairman at Integrated Proteins.
Executive directors at Integrated Proteins are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Integrated Proteins adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Integrated Proteins, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
